1844 -- Comprehensive Cancer Care Improvement Act of 2009 | Poliscope

Comprehensive Cancer Care Improvement Act of 2009

1844

111th Congress

Health

In Committee

Legislative Progress

✓

Introduced

Committee

Floor Vote

Other Chamber

Enacted

Introduced

April 1, 2009

Latest Action

April 2, 2009

Primary Sponsor

Lois CappsDemocratic(CA)

Momentum (last 30 days)

score

0 actions · 0 new cosponsors · 0 votes

Speed vs cohort

37pct

1d open

vs 6,490 other HR bills in the 111th — cohort avg 44d

Summary

No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.

Lobbying filings that explicitly cite this bill (50)

These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.

Filing registrants (13)

BRYAN CAVE LEIGHTON PAISNER (5)FAEGRE DRINKER BIDDLE & REATH LLP (6)DOWNEY MCGRATH GROUP, INC. (7)Polsinelli PC (3)TURNER & GOSS LLP (9)AMERICAN SOCIETY FOR RADIATION ONCOLOGY (10)ASTELLAS PHARMA US, INC. (6)American Society of Clinical Oncology, Inc. (8)NATIONAL ASSOCIATION OF SOCIAL WORKERS (2)NATIONAL COALITION FOR CANCER SURVIVORSHIP (11)

Show 3 more registrants

NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE

Cosponsors (73)

Name	Party	State
André Carson	Democratic	IN
Anh Cao	Republican	LA
Barney Frank	Democratic	MA

Similar Bills (AI)

Bills with similar content found using semantic analysis.

700

118th

Expressing support for the designation of September 2023 as "National Prostate Cancer Awareness Month".

1206

118th

Expressing support for the designation of May 2024 as "Mental Health Awareness Month".

507

119th

Expressing support for the designation of June 10 as "FSGS Awareness Day".

Sources: Congress.gov

AMERICAN SOCIETY FOR RADIATION ONCOLOGYclient→AMERICAN SOCIETY FOR RADIATION ONCOLOGY

2010 · fourth_quarter · Medicare/Medicaid

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services.Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for Medicare and Medicaid Extenders Act of 2010 (H.R. 4994) to avoid a 25 percent cut to physicians' Medicare payments in 2012. Support for Comprehensive Cancer Care Improvement Act of 2009 (H.R.1844) to expand cancer care planning, comprehensive symptom management and to authorize demonstrations for hospice and palliative care for cancer patients. Support for Medicare Cancer Patient Database and Coverage Act of 2009 (H.R. 3095) to provide Medicare coverage for cancer patients. Support for Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2010 (S. 3737, H.R. 3652).

Client expense: $140,044 · Firm income: Not reported

H.R.1844

CYNTHIA TOMLINSON EMILY WILSON mr DAVID ADLER mr RICHARD MARTIN esq mrs JENNIFER FINNEGAN ms SHANDI BARNEY

Government targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE

ONCOLOGY NURSING SOCIETYclient→FAEGRE DRINKER BIDDLE & REATH LLP

2010 · fourth_quarter · Medicare/Medicaid

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

S. 63 - Medicaid Advanced Practice Nurses and Physician Assistants Access Act of 2009; S. 54/H.R. 2273 - Registered Nursing Staffing Act; Medicare Quality Cancer Care Demonstration; Medicare Hospital Outpatient Supervision Requirements; H.R. 1927 - Assuring and Improving Cancer Treatment Education and Cancer Symptom Management Act; Health Reform; H.R. 2939 - Oncology Care Quality Improvement Act of 2009; Medicare Reimbursement for Cancer Care; S. 1773/H.R. 1844 - Comprehensive Cancer Care Improvement Act; H.R. 3962 - Affordable Health Care for America Act; H.R. 3590 - Patient Protection and Affordable Care Act; H.R. 4872 - Reconciliation Act of 2010; S. 717/H.R. 6224 - 21st Century Cancer ALERT (Access to Life-Saving Early Detection, Research and Treatment) Act.

Client expense: Not reported · Firm income: $40,000

H.R. 1844

COURTNEY YOHE ILISA HALPERN PAUL JEREMY SCOTT REBECCA MCGRATH RENE QUASHIE

NATIONAL COALITION FOR CANCER SURVIVORSHIPclient→NATIONAL COALITION FOR CANCER SURVIVORSHIP

2010 · fourth_quarter · Medicare/Medicaid

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Comprehensive Cancer Care Improvement Act, HR 1844/S 1773

Client expense: $10,000 · Firm income: Not reported

HR 1844

MELISSA GLIM

Government targets: HOUSE OF REPRESENTATIVES, SENATE

ONCOLOGY NURSING SOCIETYclient→FAEGRE DRINKER BIDDLE & REATH LLP

2010 · third_quarter · Medicare/Medicaid

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

S. 63 - Medicaid Advanced Practice Nurses and Physician Assistants Access Act of 2009; S. 54/H.R. 2273 - Registered Nursing Staffing Act; Medicare Quality Cancer Care Demonstration; Medicare Hospital Outpatient Supervision Requirements; H.R. 1927 - Assuring and Improving Cancer Treatment Education and Cancer Symptom Management Act; Health Reform; H.R. 2939 - Oncology Care Quality Improvement Act of 2009; Medicare Reimbursement for Cancer Care; S. 1773/H.R. 1844 - Comprehensive Cancer Care Improvement Act; H.R. 3962 - Affordable Health Care for America Act; H.R. 3590 - Patient Protection and Affordable Care Act; H.R. 4872 - Reconciliation Act of 2010; S. 717/H.R. 6224 - 21st Century Cancer ALERT (Access to Life-Saving Early Detection, Research and Treatment) Act.

Client expense: Not reported · Firm income: $40,000

H.R. 1844

COURTNEY YOHE ILISA HALPERN PAUL JEREMY SCOTT REBECCA MCGRATH RENE QUASHIE

Show 46 more cited filings

ASTELLAS PHARMA US, INC.client→ASTELLAS PHARMA US, INC.

2010 · fourth_quarter · Medicare/Medicaid

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565). The Health Care and Education Reconciliation Act of 2010 (HR 4872); the Patient Protection and Affordable Care Act (HR 3590); and the Affordable Health Care for America Act (HR 3962). Issues related to oncology coverage and Medicare clinical trials (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)).

Client expense: $380,000 · Firm income: Not reported

HR 1844

BRIAN CORRIGAN MICHAEL RUGGIERO SAMANTHA VENTIMIGLIA

Government targets: HOUSE OF REPRESENTATIVES, SENATE

NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICAREclient→NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE

2010 · first_quarter · Medicare/Medicaid

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Medicare/Part B Premium Hold Harmless. H.R. 3631: Provisions extending the current "hold harmless" policy to all Medicare enrollees to ensure 2010 Part B monthly premiums remain at the current rate. Comprehensive Health Care Reform. P.L. 111-148, P.L. 111-152, H.R. 4872, H.R. 3590: provisions related to reducing Medicare Advantage plan payments, reducing the coverage gap in Part D, requiring wealthier Medicare beneficiaries to pay a greater share of the cost of their premiums under Medicare Parts B and D, permitting the Department of Health and Human Services to negotiate drug prices for the Part D program, simplifying plan benefit designs under Part C, expanding benefits for low-income beneficiaries under the Medicare Savings Programs and the Part D Low-Income Subsidy (LIS), improving the process for reassigning LIS beneficiaries to new plans, expanding coverage of prevention services establishing a Medicare Commission, providing expanded Medicaid coverage for home and community-based services, expanding Medicaid coverage of attendant and other home services and supports, establishing a new national insurance program for long-term supports and services, authorizing funding to provide language services to limited English proficiency beneficiaries, authorizing the collection of data regarding disparities in the provision of care, providing safeguards and subsidies to assure affordability of health coverage for seniors, preserving state benefit laws and requirements, reducing permitted age rating ratio for insurance premiums, inclusion of patient-centered quality reporting requirements for providers, creating new claims reviews processes and provider certification, requiring reporting by practitioners of gifts received from pharmaceutical and medical device manufacturers. Medicare/Commission. P.L. 111-148, P.L. 111-152, H.R. 4872: creating an independent commission authorized to establish Medicare payment and policy designed to reduce Medicare spending growth. Medicare/Prescription Drug Plan. S. 330, H.R. 684: authorizing the establishment of a Medicare-operated prescription drug plan; S. 266: authorizing the Secretary of Health and Human Services to negotiate lower prescription drug prices. Medicare/Part D Generics. S. 75: requiring the use of generics where available unless the brand name drug is determined to be medically necessary. Medicare/Part D cost-sharing. S. 1630: establishing limits on required beneficiary cost-sharing under Part D drug plans. Medicare/Part D dual eligibles. P.L. 111-148, P.L. 111-152, H.R. 4872, S. 1634: removing enrollment barriers for low-income beneficiaries and establishing a Medicare-operated prescription drug plan. Medicare/Combating Waste, Fraud, Abuse. P.L. 111-148, P.L. 111-152, H.R. 4872, H.R. 27: relating to provisions to combat waste, fraud, and abuse within Medicare; H.R. 203: increasing civil and criminal penalties for acts involving fraud and abuse and increasing the surety bond amount for suppliers of durable medical equipment. Medicare/Therapy Caps. P.L. 111-148, P.L. 111-152, H.R. 4872, H.R. 3590, H.R. 43, S. 46: repealing or extending exceptions to outpatient rehabilitation therapy caps. Medicare/Private Contracts. H.R. 164: prohibiting denial of Social Security benefits to persons who elect not to participate in Medicare. Medicare/Hearing Coverage. H.R. 504: authorizing coverage of hearing aids and auditory rehabilitation services under Medicare Part B. Medicare/Dental Coverage. H.R. 870: authorizing coverage under Part B for medically necessary dental procedures. Medicare/Rural Improvements. H.R. 902/S. 382: provision authorizing improvements to services provided to beneficiaries residing in rural areas. Medicare/Shingles Vaccine. H.R. 1038: extending Part B coverage to the shingles vaccine. Medicare/Home Health. H.R. 1094: authorizing home health care agencies to assign the most appropriate skilled service to make the initial assessment visit under a Medicare home health plan of care for rehabilitation services. Medicare/Health Care Vouchers. H.R. 1118: authorizing Medicare-eligible seniors to elect to receive vouchers for a health savings account, premiums for a high deductible health insurance plan, or both, in lieu of regular Medicare benefits and suspending Medicare late enrollment penalties between ages 65 and 70. Medicare/Skilled Nursing Facilities. H.R. 1125, S. 647: provisions related to requiring the reporting of expenditures for nursing services at skilled nursing facilities and requiring disclosure of corporate ownership. Medicare/Prevention. H.R. 1213: provisions authorizing ultrasound screening for abdominal aortic aneurysms to at-risk Medicare beneficiaries between the ages of 65 and 75 without the requirement of a prior initial preventive physical examination; H.R. 1894, S. 769: expanding access to bone mass measurement benefits under Part B. Medicare/Part B Drug Payments. P.L. 111-148, P.L. 111-152, H.R. 4872, H.R. 3590, H.R. 1392: relating to appropriate Part B payment amounts for drugs and biologicals. Medicare/Low Income Prescription Drug Benefits. P.L. 111-148, P.L. 111-152, H.R. 4872, H.R. 3590, H.R. 1407, S. 534: authorizing a reduction in cost-sharing under Part D for non-institutionalized, full-benefit dual eligible individuals. Medicare/Disability Benefits. S. 700, H.R. 1708, H.R. 2881: phasing-out the 24-month waiting period for disabled individuals to become eligible for Medicare benefits and eliminating the waiting period for individuals with life-threatening conditions. Medicare/Prescription Drugs for kidney transplants. H.R. 1458, S. 565: provision related to continued coverage for immunosuppressive drugs furnished to beneficiaries that have received kidney transplants and whose entitlement to coverage would otherwise expire. Medicare/Intravenous Drugs. H.R. 1765, S.701: relating to the payment for intravenous immune globulin (IVIG) for the treatment of primary immune deficiency diseases in a patient's home and for certain disposable pumps as durable medical equipment in place of non-disposable pumps. Medicare/Home Infusion Therapy. H.R. 574, S.254: extending Medicare coverage to home infusion therapy. Medicare/Physical Therapy Services. H.R. 1829: authorizing physical therapists to evaluate and treat Medicare beneficiaries without physician referral. Medicare/Part D Premiums. H.R. 1832: limiting Part D premium increases to no more than the Social Security cost-of-living adjustment and requiring the Secretary of Health and Human Services to negotiate lower prescription drug prices. Medicare/Cancer Hospice and Palliative Care. H.R. 1844: provisions authorizing coverage of comprehensive cancer care planning, establishing a Medicare hospice care demonstration, and authorizing grant programs for cancer palliative care and symptom management, provider education, and related research. Medicare/Hospice and Advanced Care Planning. S. 1150, H.R. 2911: provisions related to changing hospice payments and providing advance care planning resources. Medicare/Physician-Manufacturer Transparency. P.L. 111-148, P.L. 111-152, H.R. 4872, H.R. 3590, S. 301: increasing the transparency of the relationship between physicians and the manufacturers of drugs, devices, biologicals, and medical supplies. Medicare/Care Coordination Services. P.L. 111-148, P.L. 111-152, H.R. 4872, H.R. 3590, S. 1131, H.R. 2560: provisions establishing pilot care coordination programs. Medicaid/Home and Community-based Long Term Care. P.L. 111-148, P.L. 111-152, H.R. 4872, H.R. 3590, S. 434, S.1257, H.R. 28552: provisions to remove barriers to providing home and community-based services including providing a state option to provide home and community-based services to individuals for whom such services are likely to prevent, delay, or decrease the likelihood of an individual's need for institutionalized care and authorizing the implementation of assistance grants for states electing to provide home and community-based services under Medicaid; provisions to provide a single point of entry to long term services; provisions to support nursing home diversion programs. Medicaid/Community-based Attendant Services and Supports. P.L. 111-148, P.L. 111-152, H.R. 4872, H.R. 3590, S. 683, H.R. 1670: authorizing coverage of community-based attendant services and supports under Medicaid, increasing funding and establishing a demonstration program for beneficiaries dually eligible for Medicare and Medicaid. P.L. 110-275, P.L. 108-173: implementation of regulations and guidance relating to beneficiary eligibility, enrollment, and effectiveness of exceptions and appeals processes under Medicare Parts C and D.

Client expense: $350,000 · Firm income: Not reported

H.R. 1844

BARBARA KENNELLY DIANE LIFSEY MARIA FREESE MAX RICHTMAN MICHAEL KIBLER RAYMOND LEIBFRIED

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE